Calderini G, Morselli P L, Garattini S
Eur J Pharmacol. 1975 Dec;34(2):345-50. doi: 10.1016/0014-2999(75)90261-7.
I.p. administration of d-amphetamine sulphate and fenfluramine-HCl at various doses induced significant modifications of brain noradrenaline (NA) and MOPEG-SO4 (3-methoxy-4-hydroxyphenylethyleneglycol) in the rat. Both drugs induced a decrease in brain noradrenaline but the two compounes seem to interact with the central noradrenergic system through a different mechanism. The decreased levels of noradrenaline after 1-fenfluramine administration were paralleled by increased MOPEG-SO4 levels. The d-isomer of fenfluramine was less active than the l-isomer. Amphetamine was considerably more effective than l-fenfluramine in reducing NA concentration. However, in spite of the long lasting effect on noradrenaline levels the i.p. administration of amphetamine did not lead to an increased MOPEG-SO4 concentration suggesting a more complex interaction with the noradrenergic system.
腹腔注射不同剂量的硫酸右旋苯丙胺和盐酸芬氟拉明可引起大鼠脑内去甲肾上腺素(NA)和3-甲氧基-4-羟基苯乙二醇(MOPEG-SO4)的显著变化。两种药物均可导致脑内去甲肾上腺素水平降低,但这两种化合物似乎通过不同机制与中枢去甲肾上腺素能系统相互作用。给予左旋芬氟拉明后去甲肾上腺素水平降低的同时,MOPEG-SO4水平升高。芬氟拉明的右旋异构体活性低于左旋异构体。苯丙胺在降低NA浓度方面比左旋芬氟拉明有效得多。然而,尽管腹腔注射苯丙胺对去甲肾上腺素水平有持久影响,但并未导致MOPEG-SO4浓度升高,这表明其与去甲肾上腺素能系统的相互作用更为复杂。